The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Clinical research
Thirty-day outcome and vascular complications after transarterial aortic valve implantation using both Edwards SAPIEN™ and Medtronic CoreValve® bioprostheses in a mixed population
Didier Tchetche1*, MD; Nicolas Dumonteil2, MD; Antoine Sauguet1, MD; Fleur Descoutures1, MD; Andre Luz1, MD; Olivier Garcia1, MD; Philippe Soula1, MD; Yannick Gabiache1, MD ; Gérard Fournial2, MD; Bertrand Marcheix2, MD; Didier Carrie2, MD; Jean Fajadet1, MD
1. Clinique Pasteur, Toulouse, France; 2. Hôpital Rangueil, Toulouse, France
Aims: Transcatheter aortic valve implantation (TAVI) is performed through a transarterial approach with encouraging results in «one-type valve» registries. We report 30-day data from a mixe